Sodium orthovanadate
Names | |
---|---|
IUPAC name
Sodium vanadate(V) | |
Other names
sodium vanadate (V), sodium vanadium oxide | |
Identifiers | |
13721-39-6 | |
ChEMBL | ChEMBL179166 |
| |
Jmol-3D images | Image |
PubChem | 61671 |
RTECS number | YW1120000 |
| |
Properties | |
Na3VO4 | |
Molar mass | 183.908 g/mol |
Appearance | white powder |
Density | 2.16 g/cm³, solid |
Melting point | 858 °C (1,576 °F; 1,131 K) |
22.17 g/100 mL | |
Solubility | insoluble in ethanol |
Structure | |
Crystal structure | cubic |
Thermochemistry | |
Specific heat capacity (C) |
164.8 J/mol K |
Std molar entropy (S |
190 J/mol K |
Std enthalpy of formation (ΔfH |
-1757 kJ/mol |
Hazards | |
Main hazards | Harmful. |
NFPA 704 | |
Flash point | Non-flammable |
LD50 (Median lethal dose) |
330 mg/kg (oral, rat) |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
verify (what is: / ?) | |
Infobox references | |
Sodium orthovanadate is the chemical compound Na3VO4 and contains the tetrahedral VO43−.[1] It is an inhibitor of protein tyrosine phosphatases, alkaline phosphatases and a number of ATPases, most likely acting as a phosphate analogue. The VO43− ion binds reversibly to the active sites of most protein tyrosine phosphatases.
It is often added to buffer solutions that are used in protein analysis in molecular biology. The aim is to preserve the phosphorylation of proteins of interest by inhibiting endogenous phosphatases present in cell lysate mixture. It is commonly used at a final working concentration of 1 - 10 mM. It is toxic when inhaled, swallowed or in contact with skin.
Synthesis
Sodium orthovanadate is created by dissolving vanadium(V) oxide in a solution of sodium hydroxide.
References
- ↑ Greenwood, Norman N.; Earnshaw, Alan (1997). Chemistry of the Elements (2nd ed.). Butterworth-Heinemann. ISBN 0080379419.
- Swarup, G. et al. Biochem. Biophys. Res. Comm. 107: 1104-1109 (1982).
See also
|